Man in Biological Technology
Navigation Links
Man in Biological Technology
Delaware Man Spearheads Brain Tumor Awareness
WILMINGTON, Del., Sept. 29 /PRNewswire/ -- If one Delaware man's vision comes true, Americans will become just as familiar with brain tumors as they are with breast cancer, and to get started on that, he's spearheading Get Your Head in the Game(R), an awareness campaign in his home state this ...Whole Genomes From Microbes to Man
Madison, WI-- Optical Mapping is a new technology that will be used to discover why patients experience toxic side effects, or fail to respond to medication and to identify the causes of antibiotic resistance and virulence in pathogenic organisms. Wisconsin- based OpGen, has announced the commercia...Exclusive Interview With Dick Leazer: Renaissance Man
Madison, WI, Jan. 21 - From 1993 through 1999, Dick Leazer served as managing director of the Wisconsin Alumni Research Foundation (WARF), the licensing and commercialization agency of the University of Wisconsin. Since then, he has co-managed the Wisconsin Investment Partners (WIP), an angel inves...Looking Older Than You Are May Have Little to Do With Wrinkles
...Permanente in Los Angeles. She developed and oversaw the clinic for HIV lipoatrophy, the condition for which Sculptra was first used in the U.S. After man hundreds of patient visits and remarkable results, Dr. Fitzgerald's research became focused on the cosmetic applications for restoring facial volume d...... red carpet, live and silent auctions and star-studded entertainment, will include performances by multiple Grammy-winning superstar Elton John, funny man Billy Crystal and recording legends Gladys Knight and Tony Bennett. Some of the celebrity guests attending the red carpet and Gala will include ...
...modes of action. Clavis Pharma's objective is to develop its drug candidates until significant value has been created and proof of principle in man has been shown. For further clinical development and commercialisation of the products, Clavis Pharma will enter into strategic partnerships with esta...
...l pay Moffitt an up-front fee, as well as predefined advanced milestone payments during the development of Debio 0928. First entry of the product into man is expected for 2012. "This discovery, made by the collaboration between Drs. Srikumar Chellappan, Said Sebti, and Nicholas Lawrence at Moffitt...
...modes of action. Clavis Pharma's objective is to develop its drug candidates until significant value has been created and proof of principle in man has been shown. For further clinical development and commercialisation of the products, Clavis Pharma will enter into strategic partnerships with esta...
DNA Diagnostics Center Offers Father's Day DNA Testing
...ting that can answer the question, "Where did my dad's ancestors begin?" DNA can trace male lineage back tens of thousands of years, and any man can find out where his paternal ancestors started--was it the foothills of the Himalayas, or Sub-Saharan Africa? The Emerald Island of Ireland, or the...... A 71-year old man with inoperable lung cancer is able to receive stereotactic body radiotherapy (SBRT) treatment DOVER, N.H., May 26 /PRNewswire-FirstCall/ -- Surg...
Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors
...a personal interest in the development of our staff at all levels. He is a man of high integrity and honesty who acted in the best interests of our shareh...strong advocate for our employees. He is genuinely a very sincere and good man who is beloved by all of us including Directors and staff. We will miss hi...CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies
...The Company hopes to commence clinical trials in humans in order to demonstrate that the L.E.A.P.S. vaccine act and stimulate human dendritic cells in man in a similar manner as seen to isolated murine and human dendritic cells ex vivo and in vivo in the mouse. Dendritic cells direct the subsequent immun...... Central Texas man receives groundbreaking therapy days after heart attack AUSTIN, Texas,...gist with Austin Heart cardiology group treated a 58-year-old Central Texas man with the experimental adult stem cell treatment, just days after his first ...
Heart Disease: An Epidemic For Firefighters
...e. "This wasn't the first firefighter in my department to die but I wanted to do something to make it among the last," says Chief Rolader. "This man was 53 years old, in great physical shape and he had no known symptoms of heart disease. We also had lost several newly-retired firefighters to sudde...PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting
...arch 20. PAREXEL Early Phase experts will be available at Booth 111 in the exhibit hall to discuss how the Company's fully integrated First in man through Proof of Concept services can help biopharmaceutical companies generate better and faster go/no go decisions about their compounds and return ......tivity, such as AGX1053 and AGX51, are the first in a class of new and unique anti-tumor agents. With sufficient funding we plan to have both drugs in man in 9 to 12 months. Our technology offers a potentially more effective and, therefore, a more cost effective anti-angiogenic based therapy for cancer t...
Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
...ion is made to the T-cell's CCR5 gene it is permanently disrupted. "Our ZFN approach is very well-validated by naturally occurring mutations in man and the recent bone marrow transplant report," commented Dale Ando, M.D., Sangamo's vice president of therapeutic development and chief medical office...Mach One Completes Note Exchange
...s have extensive experience in the 'healthy food' sector which is part of our mission of building a global company focusing on the 'health benefits to man and animal.' Execution of both capital formation and board oversight are important components of building a successful public company." Safe ...vProtect(TM) Luminal Shield Stabilizes Life-Threatening Plaque
...al Shield in the left anterior descending (LAD) coronary artery of the patient at Erasmus Medical Center in Rotterdam in June of 2008. The 64-year-old man is enrolled in SECRITT I, a pilot study designed to evaluate the vProtect(TM) Luminal Shield as a treatment for vulnerable plaques--"silent" atheroscl...New Video Streaming Site Created by Ambrose Video Publishing
...bbon in the American Film Festival, the scope of the series covers 19 countries, 150 locations and required over 14 months of filming. Ascent of man is the classic series that the New York Times called "quite simply a milestone in programming". Dr. Jacob Bronowski's unorthodox, non-scrip...New Online Video Features Brazilian Researcher Elbio Rech
...ucts that improve farm productivity and food quality. Editor's Note: Pesticides registered by the U.S. EPA will not cause unreasonable effects on man or the environment, when used in accordance with label directions. CONTACT Ranjana Smetacek 314-694-2642 ### Read the full story at http:/...'Far From Beyond': A Glimpse into the World of Biotechnology and the Future of the Free World
...h near a creek on his grandfather's farm. Stand with his wife Kate, and a team of doctors at the foot of his hospital bed wondering why such a healthy man suddenly blacked out and collapsed while on the golf course. Fight alongside his daughter, Amelia, as she struggles to survive in a world that seems "......o quickly, these two can get in and out of the office faster and spend more quality time together." Another patient, Raymond Kelly, is a 72-year-old man with stage 3 lung cancer that has spread to his lymph nodes on both sides. "With earlier forms of radiation therapy, once a tumor spreads to this degr...
...e information about the company, please visit the company's website at http://www.genodyssee.com About GEA007.1 GEA007.1 is a novel and first in man natural human IFN alpha protein variant identified using the company's proprietary natural evolution technology. It is found in all major human popula...
BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board
...onored and excited by Dr. Augustine joining our Board of Directors. He is a man of truly remarkable talents in science, engineering and public policy, and beyond that, a man distinguished by his service to all Americans whether as Chairman of the Am...Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment
...ation that are caused by a benign enlargement of the prostate. Every second man over 60 and nearly every man over 80 experience the problem in one form or another," says Dr. Ronald F. ...Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
...Board of Directors. The wisdom and expertise Dr. Shannon brings to Medizone is unparalleled in the history of our company. I consider him a remarkable man and feel honored to be able to refer to him as a professional associate. This appointment signals an immense step forward in the reorganization of Med...Is GMO Food and Organic Food an Either/Or Proposition?
... others when it comes to finding good and nutritious food? Let's find out," says an improv comic who narrates the video and interviews "the man on the street" to capture the varied opinions and perceptions of consumers. Dr. Bruce Chassy from the Department of Food Science and Human N...JAMA Commentary Opposes Criminal Punishment for HIV Exposure/Transmission
...mer partner was infected, was criminally liable for having unprotected sex with a later partner who became infected. In May, a Texas court sentenced a man with HIV to 35 years in prison for spitting on a police officer, although the chances that the officer was exposed to the virus were virtually zero. S...AFL To Return to Oklahoma Due to Overwhelming Demand for Signalife Heart Screening
...cal 16 year old, which on its own justifies our program. I plan to be back in Ada to help raise awareness about heart disease and visit with the young man and his family." The Foundation is performing heart screening at its trailer at the Carl Albert Hospital until Friday July 18, and will then move it...PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
...d patient populations in a time-efficient manner. PAREXEL, which is a top provider of expertise-based early phase development services from First in man to Proof of Concept, utilizes strategic locations, state-of-the-art technology, and highly qualified and experienced personnel to optimize time and co......r. Analoui to our team at Charlesson. His wealth of expertise in drug development will be of great value to Charlesson as we move towards our first in man studies with our lead compounds," said Mr. Moradi. About Diabetic Retinopathy and Macular Degeneration Diabetic Retinopathy is the one of the most...
ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis
...ed by Benoit de Varennes, MD, MSc, FRSC, Chairman, Division of Cardiac Surgery at McGill University in Montreal, Canada. The patient was a 76-year-old man with aortic valve stenosis. The valve replacement was successful and the patient has been discharged from the hospital in good condition. (Logo: ht...Chem Rx Corporation Reports Full Year 2007 Financial Results
...Interest income 1,969 37 (1,969)(c) 37 Interest expense -- (1,342) (13,617)(d) (14,959) Key man life insurance -- 10,000 (10,000)(e) -- Other income, net -- 650 -- 650 TOTAL OTHER......s very seriously and intend to vigorously pursue this patent infringement case," said Dr. Andre Choulika, CEO and co-founder of Cellectis SA., and the man who participated in coining the term "meganuclease." Since its creation in January 2000 and throughout its development, Cellectis has made special e...
Signalife & Athletes Foundation Dispatch Mobile Health Center to Super Bowl
...e these efforts possible. Reggie White was a great man who I knew as a dear friend for many years -- goin...ays together at the University of Tennessee. For a man with all the goodness of Mr. White as a person, an... -- maker of the Fidelity 100 -- continued: "For a man as impressive, both on off the playing field, as R......lting from our efforts in the current quarter." $3 Million Insurance Settlement Received RG Global received $3 million related to a claim on a key man insurance policy it held. A portion of the funds has been used to settle litigation with a previous holder of Company convertible notes. The remainder...
ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
... practical," stated Dr. Peter Edwardson, Vice-President, Medical Technologies of ProMetic. "We have already commenced scale-up at our plant on Isle of man and will remain on target for completion of the final phase of the development program in June 2008." The PRDT prion removal technology is presently...California IVF Experts Tap Ethics Committee for Guidance
...y assumed that the use of IVF would result in unused embryos, which turned out not to be the case. The committee is currently exploring the case of a man who requested sex selection for a girl because of a pattern of father-son abuse that occurred in his family. He was afraid that he might also become m...Saddam Lawyer Applies for Pardon for Dr Crippen
... " This man Was Erroneously Convicted of Murder and a Wrong Should be put Right by Granting a Pardon" Giovanni Di Stefano ROME, October 23 /PRNewswir...Other TagsdependdependdependtubetubetubetubetubetubetubeformulationbuybuybulkNoseNoseNoseNosetackletackletackleRNAiRNAiOther Contentscraniofacialcraniofacialcraniofacialcausativecausativecausativecausativedosedosedosedosedosedosedosedoseepisodicepisodicepisodicfatiguefatiguefatiguefatiguefatiguefatigueattentionattentionattentionattentionattentionattentionattentiondirecteddirecteddirecteddirecteddirecteddirecteddirecteddirecteddirectedintointointointointointointointointointo
dependtubefeminizationformulationantimicrobialsbuybulkdistinguishesNosetacklechemoresistanceRNAitweakssacrifice
(Date:12/5/2009)... research into venom produced by snakes and spiders, venomous ... mystery. Now, a study of 158 catfish species, published ... , has catalogued the presence of venom glands and ... from the University of Michigan, USA, carried out the ... to elucidate the diversity and distribution of venomous catfish. ...
(Date:12/4/2009)... to an analysis of statewide data taken from 1998-2001, ... year were more than three times likely to report ... their insurance status during pregnancy and delivery. , ... times more likely among mothers with Medicaid coverage, and ...
(Date:12/4/2009)... is widely used by physicians and scientists to study ... has remained largely unknown whether the electrodes on the ... inside the brain. Scientists at the Max Planck Institute ... a crucial link between the activity generated within the ...
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How to read brain activity? 2Prostate Net Announces 3A Release of La Prostata Red The Prostate Net En Espanol 57016 1Prostate Net Announces 3A Release of La Prostata Red The Prostate Net En Espanol 57016 2NCCN Holds Oncology Research Best Practices Conference 57014 1NCCN Holds Oncology Research Best Practices Conference 57014 2NCCN Holds Oncology Research Best Practices Conference 57014 3David Duncan Has a Prescription for American Health Care 57012 1David Duncan Has a Prescription for American Health Care 57012 2David Duncan Has a Prescription for American Health Care 57012 3(Date:12/6/2009)... of a key segment of DNA can lead to severe ... this kind of genetic alteration can cause obesity. The results ... led by Dr Sadaf Farooqi from the University of Cambridge ... looked at 300 children with severe obesity. , The team ... known as copy number variants (CNVs). CNVs are large chunks ...
(Date:12/6/2009)... Medical College of Wisconsin, in Milwaukee, found a substantial ... cell disease complications in children. Barriers to its use ... also identified. The study led by Amanda M. ... Medical College and Children,s Research Institute at the Children,s ... Society of Hematology meeting Dec. 7, 2009, in New ...
(Date:12/6/2009)... ORLEANS, Dec. 6 Blood clotting, or ... bleeding when a blood vessel is injured. Sometimes, ... without an obvious injury or do not dissolve ... presented today at the 51st Annual Meeting of ... practice of using the anticoagulants aspirin and heparin ...
(Date:12/6/2009)... the Greater VA Healthcare System in West Los Angeles, will once ... soar to more than 5,000 veterans, active military personnel and their ... ... -- Volunteer organizations and members of the community, in cooperation with ... again create a holiday party. This year,s attendance is expected to ...
(Date:12/5/2009)... been significant scientific advances in the field of blood ... understanding of how certain diseases progress in order to ... best care. Research presented today at the 51st Annual ... induction therapies for managing multiple myeloma, the importance of ...
Breaking Medicine News(10 mins):Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8[1] Genetic studies reveal new causes of severe obesity in childhood[1] New study finds barriers to pain treatment in children with sickle cell disease[1] Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages[0] 17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” [0] New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |